Raymond James analyst Steve Moss initiates coverage on Brookline Bancorp (NASDAQ:BRKL) with a Market Perform rating.
Celyad Oncology Announces Receipt Of Nasdaq Delisting Notice
Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the "Company"), is a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies.
The Company had
